ResearcherCalifornia State University, NorthridgeNo recent work listed
Armen Gharibi
Matched on OpenAlex author ID A5110310628. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2016: 1 paper · 2017: 2 papers
Papers 3
- ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. Co-author DOI 10.1038/s41598-017-09946-z↗
- A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic canc… Co-author DOI 10.18632/oncotarget.11809↗
- Cellular and molecular aspects of pancreatic cancer. Co-author DOI 10.1016/j.acthis.2016.01.009↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jonathan A. Kelber · 3 shared papers, 2016–2017 · strength 0.23
- Paper Cellular and molecular aspects of pancreatic cancer. DOI 10.1016/j.acthis.2016.01.009↗
- Paper ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. DOI 10.1038/s41598-017-09946-z↗
- Paper A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between ort… DOI 10.18632/oncotarget.11809↗
- Malachia Y. Hoover · 2 shared papers, 2017 · strength 0.13
- Paper ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. DOI 10.1038/s41598-017-09946-z↗
- Paper A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between ort… DOI 10.18632/oncotarget.11809↗
- Matthew H. G. Katz · 1 shared paper, 2017 · strength 0.06
- Ali A. Maawy · 1 shared paper, 2017 · strength 0.06
- Michael Bouvet · 1 shared paper, 2017 · strength 0.06
- Robert M. Hoffman · 1 shared paper, 2017 · strength 0.06
- Jason B. Fleming · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.